APMA Unveils New eAdvocacy Action Center
APMA has officially launched its new eAdvocacy Action Center for members, patients and students to engage in grassroots advocacy. The platform empowers APMA members to quickly engage their members of Congress and influence federal health policy. It also provides tools to take action on critical state legislation.
Read More
CAC/PIAC Meeting Highlights Payer Trends and AI Use
Representatives and APMA staff participated in a robust discussion of payer utilization management practices, modifier advocacy, including the new 25 Modifier Progress Note Guidance, the evolving use of AI in payment review and denial, Medicare Administrative Contractor (MAC) engagement, skin substitute reimbursement concerns, and Durable Medical Equipment (DME) issues.
Read More
Diabetes Foot Bill Update
Samuel Gorelik, DPM, recently attended a Massachusetts town hall hosted by Representative Seth Moulton (D-MA), where he discussed the importance of the Diabetes Foot Health Access and Modernization Act. Representative Moulton cosponsored the legislation the very next day.
Read More
Medicare Reform Legislation
Representatives Mariannette Miller-Meeks, MD (R-IA), and Herb Conaway, MD (D-NJ), introduced the Medicare Physician Data-driven Performance Payment System Act, which would reform the Merit-based Incentive Payment System (MIPS) in Medicare. The legislation would replace MIPS with the Data-Driven Performance Payment System (DPPS), which would lower physician payment penalties and reinvest penalty funds to assist under-resourced practices.
Read More
WISeR Guidance for Skin Substitute Reviews
CMS updated the WISeR Provider and Supplier Operational Guide to remove ICD-10 codes L97.111-L97.826 from Appendix B as indications that would automatically trigger prior authorization or pre-payment review for skin substitute applications. These diagnosis codes are commonly used to describe non-pressure chronic ulcers of the lower limb and are not exclusive to DFUs or VLUs.
Read More
Alliance of Wound Care Stakeholders
APMA continues to engage in advocacy efforts through our coalition work with the Alliance for Wound Care Stakeholders, particularly on issues related to skin substitutes and physician payment. During the first quarter of 2026, the alliance supported APMA’s ongoing effort related to the revised NPU episode-based cost measure.
Read More
Preventive Care for Diabetic Patients
APMA submitted a letter responding to the House Committee on Ways and Means Health Subcommittee for a field hearing on modernizing healthcare practices for chronic condition treatment.
Read More
APMA Corporate Council
APMA is proud to acknowledge the founding members of the APMA Corporate Council: Amgen, Clutch Medical, NextGen Healthcare, PICA, Sagis Diagnostics, and Vertex Pharmaceuticals. This initiative will increase collaboration between APMA leadership, members, and key leaders across the podiatric profession.
Read More
MA Chart Review Advocacy Win
In the Medicare Advantage Risk Adjustment Data Validation Final Rule released earlier this month, Medicare Advantage plans are now disallowed from counting diagnoses that are derived only from chart review and are not linked to any service provided to the patient toward the Medicare Advantage risk scores and payments.
Read More
MedPAC Physician Classification
APMA submitted a follow up letter to the Medicare Payment Advisory Commission (MedPAC), calling for doctors of podiatric medicine (DPMs) to be consistently classified as physicians in all MedPAC reports and analyses.
Read More
APMA’s Medicaid Toolkit Updated
APMA has updated its Medicaid Toolkit with a new resource on the Medicaid-related provisions in the One Big Beautiful Bill Act (OBBBA). The toolkit equips members with practical advocacy resources, including a 50-state coverage survey, legislator talking points, fact sheets, Medicaid maps, eAdvocacy tools, and more.
Read More
